Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-22

Clinical Trial Update: Health Enhanced Artery Risk Tracking With Widespread Implementation and Screening Effort in ASCVD (HEARTWISE-ASCVD) [NA]

View source ↗

Summary

This document describes the HEARTWISE-ASCVD clinical trial, a study evaluating health-enhanced artery risk tracking with wide implementation and ASCVD screening…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Stanford University | Conditions: Atherosclerotic Cardiovascular Disease (ASCVD), Coronary Artery Calcification | NA | Status: NOT_YET_RECRUITING